Chronic rhinosinusitis: Management for optimal outcomes

Treatments in Respiratory Medicine

Volumn 3, Issue 2, 2004, Pages 97-105

  Aukema, Albertien A C ^a   Fokkens, Wytske J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; AZELASTINE; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DECONGESTIVE AGENT; FLUTICASONE PROPIONATE; HYPERTONIC SOLUTION; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; ISOTONIC SOLUTION; MACROLIDE; MOMETASONE FUROATE; MUCOLYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYMETAZOLINE; PLACEBO; PREDNISOLONE; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; UNINDEXED DRUG; XYLOMETAZOLINE;

AERATION; ALLERGY; ANAMNESIS; ATROPHY; BACTERIAL INFECTION; CHRONIC DISEASE; CILIATED EPITHELIUM; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE DURATION; DOSE RESPONSE; DRUG PENETRATION; DRUG RESPONSE; DRY NOSE; ENDOSCOPY; HUMAN; IMMUNE DEFICIENCY; INFECTION CONTROL; LAVAGE; MALAISE; MUCOSA INFLAMMATION; NOSE MUCOSA; NOSE POLYP; NOSE SURGERY; PARANASAL SINUS; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PUS; REVIEW; RHINOSINUSITIS; RISK FACTOR; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; TREATMENT INDICATION; TREATMENT PLANNING;

ALGORITHMS; ANIMALS; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; CILIA; GLUCOCORTICOIDS; HUMANS; IRRIGATION; NASAL DECONGESTANTS; NASAL POLYPS; RHINITIS; SINUSITIS;

EID: 2342637113     PISSN: 11763450     EISSN: None     Source Type: Journal    
DOI: 10.2165/00151829-200403020-00004     Document Type: Review

References (62)

1. van Agthoven M, Fokkens WJ, van de Merwe JP, et al. Quality of life of patients with refractory chronic rhinosinusitis: effects of filgrastim treatment. Am J Rhinol 2001; 15 (4): 231-7
2. Kaliner MA, Osguthorpe JD, Fireman P, et al. Sinusitis: bench to bedside: current findings, future directions. Otolaryngol Head Neck Surg 1997; 116 (6 Pt 2): S1-20
3. Melen I. Chronic sinusitis: clinical and pathophysiological aspects. Acta Otolaryngol Suppl 1994; 515: 45-8
4. de Benedictis FM, Bush A. Rhinosinusitis and asthma: epiphenomenon or causal association? Chest 1999; 115 (2): 550-6
5. Van der Baan S, Fokkens WJ. Mucosa and mucus [in Dutch]. In: Brenkman CJ, de Vries N, editors. The report of the Dutch otorhinolaryngology/HNS society: Neusbijholtechirurgie - goedaardige aandoeningen. The Hague: Kugler Publications/SPB Academic Publishing bv, 2002: 57-62
6. Fokkens WJ, van der Baan S. Non-surgical therapy [in Dutch]. In: Brenkman CJ, de Vries N, editors. The report of the Dutch otorhinolaryngology/HNS society: Neusbijholtechirurgie - goedaardige aandoeningen. The Hague: Kugler Publications/SPB Academic Publishing bv, 2002: 131-9
7. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 1997; 117 (3 Pt 2): S1-7
8. Konen E, Faibel M, Kleinbaum Y, et al. The value of the occipitomental (Waters') view in diagnosis of sinusitis: a comparative study with computed tomography. Clin Radiol 2000; 55 (11): 856-60
9. Al-Rawi MM, Edelstein DR, Erlandson RA. Changes in nasal epithelium in patients with severe chronic sinusitis: a clinicopathologic and electron microscopic study. Laryngoscope 1998; 108 (12): 1816-23
10. Hadfield PJ, Rowe-Jones JM, Mackay IS. The prevalence of nasal polyps in adults with cystic fibrosis. Clin Otolaryngol 2000; 25 (1): 19-22
11. Rowe-Jones JM, Trendell-Smith N, Shembekar M, et al. Polypoid rhinosinusitis in patients with host defence deficiencies: cellular infiltration and disease severity. Rhinology 1997; 35 (3): 113-7
12. Wojtczak HA, Kerby GS, Wagener JS, et al. Beclomethasone diproprionate reduced airway inflammation without adrenal suppression in young children with cystic fibrosis: a pilot study. Pediatr Pulmonol 2001; 32 (4): 293-302
13. Karlsson G, Holmberg K. Does allergic rhinitis predispose to sinusitis? Acta Otolaryngol Suppl 1994; 515: 26-8
14. Emanuel IA, Shah SB. Chronic rhinosinusitis: allergy and sinus computed tomography relationships. Otolaryngol Head Neck Surg 2000; 123 (6): 687-91
15. Blair C, Nelson M, Thompson K, et al. Allergic inflammation enhances bacterial sinusitis in mice. J Allergy Clin Immunol 2001; 108 (3): 424-9
16. Bachert C, Wagenmann M, Hauser U, et al. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 1997; 99 (6 Pt 1): 837-42
17. Hedman J, Kaprio J, Poussa T, et al. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999; 28 (4): 717-22
18. Larsen K. The clinical relationship of nasal polyps to asthma. Allergy Asthma Proc 1996; 17 (5): 243-9
19. Settipane GA, Chafee FH. Nasal polyps in asthma and rhinifis: a review of 6037 patients. J Allergy Clin Immunol 1977; 59 (1): 17-21
20. Caplin I, Haynes JT, Spahn J. Are nasal polyps an allergic phenomenon? Ann Allergy 1971; 29 (12): 631-4
21. Rhyoo C, Sanders SP, Leopold DA, et al. Sinus mucosal IL-8 gene expression in chronic rhinosinusitis. J Allergy Clin Immunol 1999; 103 (3 Pt 1): 395-400
22. Bachert C, Wagenmann M, Rudack C, et al. The role of cytokines in infectious sinusitis and nasal polyposis. Allergy 1998; 53 (1): 2-13
23. Vento SI, Ertama LO, Hytonen ML, et al. Nasal polyposis: clinical course during 20 years. Ann Allergy Asthma Immunol 2000; 85 (3): 209-14
24. Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999; 74 (9): 877-84
25. Schubert MS. A superantigen hypothesis for the pathogenesis of chronic hypertrophic rhinosinusitis, allergic fungal sinusitis, and related disorders. Ann Allergy Asthma Immunol 2001; 87 (3): 181-8
26. Chee L, Graham SM, Carothers DG, et al. Immune dysfunction in refractory sinusitis in a tertiary care setting. Laryngoscope 2001; 111 (2): 233-5
27. Bachmann G, Hommel G, Michel O. Effect of irrigation of the nose with isotonic salt solution on adult patients with chronic paranasal sinus disease. Eur Arch Otorhinolaryngol 2000; 257 (10): 537-41
28. Taccariello M, Parikh A, Darby Y, et al. Nasal douching as a valuable adjunct in the management of chronic rhinosinusitis. Rhinology 1999; 37 (1): 29-32
29. Homer JJ, England RJ, Wilde AD, et al. The effect of pH of douching solutions on mucociliary clearance. Clin Otolaryngol 1999; 24 (4): 312-5
30. Talbot AR, Herr TM, Parsons DS. Mucociliary clearance and buffered hypertonic saline solution. Laryngoscope 1997; 107 (4): 500-3
31. Boek WM, Keles N, Graamans K, et al. Physiologic and hypertonic saline solutions impair ciliary activity in vitro. Laryngoscope 1999; 109 (3): 396-9
32. Di Lorenzo G, Gervasi F, Drago A, et al. Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics. Clin Exp Allergy 1999; 29 (10): 1367-77
33. Kleinjan A, Holm AF, Dijkstra MD, et al. Preventive treatment of intranasal fluticasone propionate reduces cytokine mRNA expressing cells before and during a single nasal allergen provocation. Clin Exp Allergy 2000; 30 (10): 1476-85
34. Lund VJ, Flood J, Sykes AP, et al. Effect of fluticasone in severe polyposis. Arch Otolaryngol Head Neck Surg 1998; 124 (5): 513-8
35. Meltzer EO, Orgel HA, Backhaus JW, et al. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin Immunol 1993; 92 (6): 812-23
36. Sykes DA, Wilson R, Chan KL, et al. Relative importance of antibiotic and improved clearance in topical treatment of chronic mucopurulent rhinosinusitis: a controlled study. Lancet 1986; II (8503): 359-60
37. Qvarnberg Y, Kantola O, Salo J, et al. Influence of topical steroid treatment on maxillary sinusitis. Rhinology 1992; 30 (2): 103-12
38. Parikh A, Scadding GK, Darby Y, et al. Topical corticosteroids in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial using fluticasone propionate aqueous nasal spray. Rhinology 2001; 39 (2): 75-9
39. Holm AF, Godthelp T, Fokkens WJ, et al. Long-term effects of corticosteroid nasal spray on nasal inflammatory cells in patients with perennial allergic rhinitis. Clin Exp Allergy 1999; 29 (10): 1356-66
40. Holm AF, Fokkens WJ, Godthelp T, et al. A 1 -year placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: a safety and biopsy study. Clin Otolaryngol 1998; 23 (1): 69-73
41. Qvarnberg Y, Valtonen H, Laurikainen K. Intranasal beclomethasone dipropionate in the treatment of common cold. Rhinology 2001; 39 (1): 9-12
42. Penttila M, Poulsen P, Hollingworth K, et al. Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 microg once daily and twice daily in the treatment of bilateral nasal polyposis: a placebo-controlled randomized study in adult patients. Clin Exp Allergy 2000; 30 (1): 94-102
43. van Camp C, Clement PA. Results of oral steroid treatment in nasal polyposis. Rhinology 1994; 32 (1): 5-9
44. Klossek JM, Dubreuil L, Richet H, et al. Bacteriology of chronic purulent secretions in chronic rhinosinusitis. J Laryngol Otol 1998; 112 (12): 1162-6
45. Brook I, Frazier EH. Correlation between microbiology and previous sinus surgery in patients with chronic maxillary sinusitis. Ann Otol Rhinol Laryngol 2001; 110 (2): 148-51
46. Grimer RJ, Karpinski MR, Andrews JM, et al. Penetration of amoxycillin and clavulanic acid into bone. Chemotherapy 1986; 32 (3): 185-91
47. Esposito S, Galante D, Barba D, et al. Ciprofloxacin concentrations in human fluids and tissues following a single oral dose. Int J Clin Pharmacol Res 1987; 7 (3): 181-6
48. Shirtliff ME, Mader JT, Calhoun J. Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits. Clin Orthop 1999; (359): 229-36
49. Kennedy DW, Senior BA, Gannon FH, et al. Histology and histomorphometry of ethmoid bone in chronic rhinosinusitis. Laryngoscope 1998; 108 (4 Pt 1): 502-7
50. Infectious rhinosinusitis in adults: classification, etiology and management. International Rhinosinusitis Advisory Board. Ear Nose Throat J 1997; 76 (12 Suppl.): 1-22
51. Cervin A. The anti-inflammatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis. Acta Otolaryngol 2001; 121 (1): 83-92
52. MacLeod CM, Hamid QA, Cameron L, et al. Anti-inflammatory activity of clarithromycin in adults with chronically inflamed sinus mucosa. Adv Ther 2001; 18 (2): 75-82
53. Zalewska-Kaszubska J, Gorska D. Anti-inflammatory capabilities of macrolides. Pharmacol Res 2001; 44 (6): 451-4
54. Yamada T, Fujieda S, Mori S, et al. Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol 2000; 14 (3): 143-8
55. Ciprandi G, Pronzato C, Passalacqua G, et al. Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity. J Allergy Clin Immunol 1996; 98 (6 Pt 1): 1088-96
56. Westerveld GJ, Scheeren RA, Dekker I, et al. Anti-oxidant actions of oxymethazoline and xylomethazoline. Eur J Pharmacol 1995; 291 (1): 27-31
57. Graf P, Juto JE. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling. Rhinology 1995; 33 (1): 14-7
58. Pang YT, Willatt DJ. Do antral washouts have a place in the current management of chronic sinusitis? J Laryngol Otol 1996; 110 (10): 926-8
59. Ricchetti A, Landis BN, Maffioli A, et al. Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol 2002; 116 (4): 261-3
60. Messerklinger W. Endoscopy technique of the middle nasal meatus [in German; author's translation]. Arch Otorhinolaryngol 1978; 221 (4): 297-305
61. Stammberger H, Posawetz W. Functional endoscopic sinus surgery: concept, indications and results of the Messerklinger technique. Eur Arch Otorhinolaryngol 1990; 247 (2): 63-76
62. Lund VJ. Evidence-based surgery in chronic rhinosinusitis. Acta Otolaryngol 2001; 121 (1): 5-9